                         SEQUENCE LISTING

<110>  The USA, as represented by the Secretary, Dept. of Health 
       and Human Services
       Fessler, Michael Brian
       Williams, Carmen J.
       Lin, Wan-Chi
 
<120>  USE OF EPITHELIAL MEMBRANE PROTEIN 2 (EMP2) TARGETING AGENTS IN 
       TREATING LUNG DISORDERS

<130>  6137NIEHS-3-PCT

<140>  PCT/US19/29801
<141>  2019-04-30

<150>  62/664,805
<151>  2018-04-30

<150>  62/771,326
<151>  2018-11-26

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  172
<212>  PRT
<213>  Mus musculus (mEMP2)

<400>  1

Met Leu Val Ile Leu Ala Phe Ile Ile Val Phe His Ile Val Ser Thr 
1               5                   10                  15      


Ala Leu Leu Phe Ile Ser Thr Ile Asp Asn Ala Trp Trp Val Gly Asp 
            20                  25                  30          


Ser Phe Ser Ala Asp Leu Trp Arg Val Cys Thr Asn Ser Thr Asn Cys 
        35                  40                  45              


Thr Glu Ile Asn Glu Leu Thr Gly Pro Glu Ala Phe Glu Gly Tyr Ser 
    50                  55                  60                  


Val Met Gln Ala Val Gln Ala Thr Met Ile Leu Ser Thr Ile Leu Ser 
65                  70                  75                  80  


Cys Ile Ser Phe Leu Ile Phe Leu Leu Gln Leu Phe Arg Leu Lys Gln 
                85                  90                  95      


Gly Glu Arg Phe Val Leu Thr Ser Ile Ile Gln Leu Met Ser Cys Leu 
            100                 105                 110         


Cys Val Met Ile Gly Ala Ser Ile Tyr Thr Asp Arg Arg Gln Asp Leu 
        115                 120                 125             


His Gln Gln Asn Arg Lys Leu Tyr Tyr Leu Leu Gln Glu Gly Ser Tyr 
    130                 135                 140                 


Gly Tyr Ser Phe Ile Leu Ala Trp Val Ala Phe Ala Phe Thr Phe Ile 
145                 150                 155                 160 


Ser Gly Leu Met Tyr Met Ile Leu Arg Lys Arg Lys 
                165                 170         


<210>  2
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CRAC Sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Leu can also be Val

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  can be 1, 2, 3, 4 or 5 amino acids

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  can be 1, 2, 3, 4 or 5 amino acids

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Lys can also be Arg

<400>  2

Leu Xaa Tyr Xaa Lys 
1               5   


<210>  3
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  CARC Sequence


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Lys can also be Arg

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  can be 1, 2, 3, 4 or 5 amino acids

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Tyr can also be Phe

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  can be 1, 2, 3, 4 or 5 amino acids

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Leu can also be Val

<400>  3

Lys Xaa Tyr Xaa Leu 
1               5   


